Literature DB >> 1532491

Stimulation of plasmin activity by oleic acid.

A A Higazi1, Z Finci-Yeheskel, A A Samara, R Aziza, M Mayer.   

Abstract

The amidolytic activity of plasmin with the chromogenic substrate H-D-valyl-L-leucyl-L-lysine p-nitroanilide (S-2251) is stimulated by oleic acid in a dose-dependent and saturable fashion. The activity of plasmin on S-2251 in the presence of oleic acid followed a sigmoidal kinetic pattern, with an almost 4-fold stimulation of activity at 60 microM-oleic acid. Half-maximal stimulation occurred at an oleic acid level of 19.5 microM. The amino acid analogue 6-aminohexanoic acid (AHA), which is known to bind to lysine-binding sites in plasmin, suppressed the stimulatory effect of oleic acid in a concentration-dependent manner; at 0.3 mM-AHA, about 70% of the oleic acid-dependent enhancement of plasmin activity was abolished. The l/v versus 1/[S] plot for plasmin changed in the presence of oleic acid from a linear to a non-linear curve, suggesting positive co-operativity. 14C-labelled oleic acid bound to plasmin, and the bound ligand was displaced by an excess of unlabelled oleic acid. Oleic acid also produced a marked (40-fold) stimulation of the plasminogen-dependent cleavage of S-2251 by urokinase. A half-maximal effect on plasminogen activation was obtained at 40 microM-oleic acid. The present findings suggest that the ability of oleic acid to stimulate plasmin activity and to enhance the conversion of plasminogen to plasmin depends on the interaction of oleic acid with specific lysine-binding sites in plasmin.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1532491      PMCID: PMC1130866          DOI: 10.1042/bj2820863

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  35 in total

1.  Characterization of an extremely large, ligand-induced conformational change in plasminogen.

Authors:  W F Mangel; B H Lin; V Ramakrishnan
Journal:  Science       Date:  1990-04-06       Impact factor: 47.728

Review 2.  Characteristics of fatty acid-binding proteins and their relation to mammary-derived growth inhibitor.

Authors:  F Spener; C Unterberg; T Börchers; R Grosse
Journal:  Mol Cell Biochem       Date:  1990 Oct 15-Nov 8       Impact factor: 3.396

Review 3.  Plasminogen activation and regulation of pericellular proteolysis.

Authors:  O Saksela
Journal:  Biochim Biophys Acta       Date:  1985-11-12

Review 4.  Biochemical and biological aspects of the plasminogen activation system.

Authors:  M Mayer
Journal:  Clin Biochem       Date:  1990-06       Impact factor: 3.281

5.  Identification of a site in fibrin(ogen) which is involved in the acceleration of plasminogen activation by tissue-type plasminogen activator.

Authors:  W Nieuwenhuizen; A Vermond; M Voskuilen; D W Traas; J H Verheijen
Journal:  Biochim Biophys Acta       Date:  1983-10-17

6.  The effect of alpha-,omega-amino acids on human plasminogen structure and activation.

Authors:  B N Violand; R Byrne; F J Castellino
Journal:  J Biol Chem       Date:  1978-08-10       Impact factor: 5.157

7.  A new method of isolation and some properties of the heavy chain of human plasmin.

Authors:  E E Rickli; W I Otavsky
Journal:  Eur J Biochem       Date:  1975-11-15

8.  On the specific interaction between the lysine-binding sites in plasmin and complementary sites in alpha2-antiplasmin and in fibrinogen.

Authors:  B Wiman; H R Lijnen; D Collen
Journal:  Biochim Biophys Acta       Date:  1979-07-25

9.  An enhancing effect of poly-lysine on the activation of plasminogen.

Authors:  R A Allen
Journal:  Thromb Haemost       Date:  1982-02-26       Impact factor: 5.249

10.  Synthesis, purification, and properties of a peptide that enhances the activation of human [Glu1]plasminogen by tissue plasminogen activator and retards fibrin polymerization.

Authors:  B A Chibber; S Urano; F J Castellino
Journal:  Int J Pept Protein Res       Date:  1990-01
View more
  9 in total

1.  Cloning of a fibrinolytic enzyme (subtilisin) gene from Bacillus subtilis in Escherichia coli.

Authors:  Younes Ghasemi; Fatemeh Dabbagh; Abdollah Ghasemian
Journal:  Mol Biotechnol       Date:  2012-09       Impact factor: 2.695

2.  Regulation of fibrinolysis by non-esterified fatty acids.

Authors:  A A Higazi; R Aziza; A A Samara; M Mayer
Journal:  Biochem J       Date:  1994-05-15       Impact factor: 3.857

3.  Binding of sulfosuccinimidyl fatty acids to adipocyte membrane proteins: isolation and amino-terminal sequence of an 88-kD protein implicated in transport of long-chain fatty acids.

Authors:  C M Harmon; N A Abumrad
Journal:  J Membr Biol       Date:  1993-04       Impact factor: 1.843

Review 4.  Matrix metalloproteinase inhibitors (MMPIs) from marine natural products: the current situation and future prospects.

Authors:  Chen Zhang; Se-Kwon Kim
Journal:  Mar Drugs       Date:  2009-03-31       Impact factor: 5.118

5.  Plasminogen binding and activation at the breast cancer cell surface: the integral role of urokinase activity.

Authors:  Gillian E Stillfried; Darren N Saunders; Marie Ranson
Journal:  Breast Cancer Res       Date:  2007       Impact factor: 6.466

6.  Fibrinolysis in a lipid environment: modulation through release of free fatty acids.

Authors:  G Rábai; B Váradi; C Longstaff; P Sótonyi; V Kristóf; F Timár; R Machovich; K Kolev
Journal:  J Thromb Haemost       Date:  2007-06       Impact factor: 5.824

Review 7.  New Insight on the Role of Plasminogen Receptor in Cancer Progression.

Authors:  Seema Kumari; Ramarao Malla
Journal:  Cancer Growth Metastasis       Date:  2015-07-29

Review 8.  Recent advances on plasmin inhibitors for the treatment of fibrinolysis-related disorders.

Authors:  Rami A Al-Horani; Umesh R Desai
Journal:  Med Res Rev       Date:  2014-03-21       Impact factor: 12.944

9.  Suppressed catalytic efficiency of plasmin in the presence of long-chain fatty acids. Identification of kinetic parameters from continuous enzymatic assay with Monte Carlo simulation.

Authors:  Anna Tanka-Salamon; Kiril Tenekedjiev; Raymund Machovich; Krasimir Kolev
Journal:  FEBS J       Date:  2008-02-12       Impact factor: 5.542

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.